Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants. - Maden CH; Fairman D; Chalker M; Costa MJ; Fahy WA; Garman N; Lukey PT; Mant T; Parry S; Simpson JK; Slack RJ; Kendrick S; et al. (European journal of clinical pharmacology, 2018)